Novavax NVAX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.49M-102% | $17.53M+122% | -$202.38M-66.8% | $106.51M-34.4% | $518.65M+452% | ||
| $3.06M-63.3% | $5.13M-59.1% | $6.59M-48.1% | $7.56M-32.1% | $8.34M-31.3% | ||
| $7.72M-24.9% | $7.97M-23.7% | $8.55M-29.0% | $9.21M-34.6% | $10.29M-11.0% | ||
| $266K— | $807K— | $97.04M— | $349K— | $0-100% | ||
| $226K+110% | —— | $3.75M— | $4.01M— | -$2.38M+85.9% | ||
| -$60.08M+71.6% | -$21.54M+49.3% | -$26.54M— | -$62.64M+33.4% | -$211.85M+22.2% | ||
| -$86.24M-16.8% | —— | -$207.93M— | $168.81M+278% | -$73.87M+75.0% | ||
| $8.97M+154% | -$1.3M-107% | —— | —— | -$16.55M-472% | ||
| -$50.95M+91.6% | -$2.37M— | -$11.71M— | -$4.87M-104% | -$604M-9,726% | ||
| -$32.42M+82.5% | -$39.48M+77.2% | —— | -$127.46M-141% | -$185.5M-122% | ||
| $1.27M-20.4% | $2.08M+7.5% | $2.02M+47.0% | $0-100% | $1.6M-76.8% | ||
| $214.13M+86.6% | —— | $235.01M+228% | —— | $114.72M— | ||
| $147.29M+243% | $98.61M-70.8% | $100.5M-4.8% | $111.63M— | $43M— | ||
| -$28.36M+61.3% | —— | -$136.53M— | $111.1M+130% | -$73.32M-911% | ||
| $46.41M— | —— | —— | —— | $0— | ||
| $578K-73.7% | $6.27M+128% | $984K+92.2% | $612K+67.2% | $2.2M+511% | ||
| $37.68M+634% | —— | $42.44M— | -$1.04M-100% | -$7.06M-220% | ||
| -$18K+98.1% | —— | $658K-89.1% | $7.91M+5,168% | -$930K+68.5% | ||
| -$23.13M+91.3% | -$27.31M+36.9% | $0+100% | -$9.5M-105% | -$266.81M-204% | ||
| $6.29M+125% | $2.93M-67.7% | $2.31M+74.8% | $7.01M+17.3% | $2.8M+132% | ||
| $1.85M+23.2% | $6K-98.1% | $3.88M+201% | $3.42M+692% | $1.5M+2,211% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $266K— | $1.5M+45.0% | —— | —— | $0-100% | ||
| -$50.95M+91.6% | -$2.37M— | -$11.71M— | -$4.87M-104% | -$604M-9,726% | ||
| -$86.24M-16.8% | —— | -$207.93M— | $168.81M+278% | -$73.87M+75.0% | ||
| $8.97M+154% | -$1.3M-107% | —— | —— | -$16.55M-472% | ||
| $0-100% | $0-100% | $566K-60.7% | $1.1M-88.6% | $276K-96.9% | ||
| $1.27M-20.4% | $2.08M+7.5% | $2.02M+47.0% | $0-100% | $1.6M-76.8% | ||
| $147.29M+243% | $98.61M-70.8% | $100.5M-4.8% | $111.63M— | $43M— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $39.75M— | —— | —— | —— | $0— | ||
| $578K-73.7% | $6.27M+128% | $984K+92.2% | $612K+67.2% | $2.2M+511% | ||
| -$8.16M-67.9% | —— | —— | -$428K-120% | -$4.86M-689% | ||
| —— | -$1.2M-468% | -$1.2M-468% | -$1.2M-468% | -$1.2M-468% | ||
| $1.85M+23.2% | $6K-98.1% | $3.88M+201% | $3.42M+692% | $1.5M+2,211% | ||
| -$33.69M+82.0% | -$41.55M+76.3% | —— | -$127.33M-141% | -$187.1M-107% | ||
| -$33.69M+82.0% | -$41.55M+76.3% | —— | -$127.33M-141% | -$187.1M-107% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Novavax generate?
- Novavax (NVAX) generated -$384.9M in operating cash flow over the trailing twelve months.
- What is Novavax's free cash flow?
- After $5.4M of capital expenditures, Novavax's free cash flow was -$389.7M over the trailing twelve months, down 288.4% year over year.
- Where does Novavax's cash flow data come from?
- Every line is extracted from Novavax's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
